I like to get this clarified. My understanding is Grandcimab is not such a game changer. I think CSL already has products in the market and therefore there will be some loss of income from those. I have seen $50 being mentioned and that is a just an estimate of the value of R&D budget CSL keeps spending. Try to monetise. I am sure someone in this group can confirm which is correct.
I like to get this clarified. My understanding is Grandcimab is...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$305.34 |
Change
4.220(1.40%) |
Mkt cap ! $147.5B | |||
| Open | High | Low | Value | Volume |
| $303.92 | $305.98 | $302.00 | $378.0M | 1.257M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 74 | $305.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $305.43 | 250 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |